Kataki A, Konstadoulakis M M
First Department of Propaedeutic Surgery, University of Athens, Hippocration General Hospital, Greece.
Genet Test. 2000;4(1):79-84. doi: 10.1089/109065700316534.
The fascinating progress of molecular biology in the last decades has made possible the early identification of persons at risk of developing malignant neoplasms, such as thyroid, colon, and breast cancer. This has changed conventional medical practice and has raised a number of ethical questions. Despite the fact that there has been substantial development throughout the Western countries in legislation dealing with medical information, there is an acute need for further exploration and assessment of the moral and social dimensions of medical practices to achieve more precise and uniform regulations. These topics were discussed in a multidisciplinary European Conference entitled "Molecular Screening of Individuals at High Risk of Developing Cancer: Medical, Ethical, Legal, and Social Issues," which took place in March, 1999, in Athens, Greece.
在过去几十年中,分子生物学取得了引人注目的进展,使得早期识别有患恶性肿瘤风险的人成为可能,比如甲状腺癌、结肠癌和乳腺癌。这改变了传统医疗实践,并引发了一些伦理问题。尽管西方国家在处理医疗信息的立法方面已经有了很大发展,但迫切需要进一步探索和评估医疗实践的道德和社会层面,以实现更精确和统一的监管。这些话题在1999年3月于希腊雅典举行的一场名为“对癌症高危个体的分子筛查:医学、伦理、法律和社会问题”的多学科欧洲会议上进行了讨论。